Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
World One-Hundred Days After Covid-19 Outbreak: Incidence, Case Fatality Rate, and Trend Publisher



Kazemikaryani A1 ; Safarifaramani R1 ; Amini S2 ; Ramezanidoroh V3, 4 ; Berenjian F5 ; Dizaj M6 ; Hashempour R5 ; Dizaj J5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Department of Health Management, Health School, Arak University of Medical Sciences, Arak, Iran
  3. 3. Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
  4. 4. Department of Health Management and Economics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  5. 5. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Psychology, Payame Noor University, Urmia, Iran

Source: Journal of Education and Health Promotion Published:2020


Abstract

BACKGROUND: The prevalence of viral diseases is on the rise and has caused many problems for public health. COVID-19 is a new viral outbreak in the world. This study aimed to investigate the trends of incidence and case fatality rate (CFR) of COVID-19 in the world by April 30, 2020. METHODS: This was a descriptive-analytical study. We investigated the number of cases and deaths in 35 selected countries and regions of the WHO that had at least 10,000 cases by the time of the study. In addition, the incidence and CFR of COVID-19 were investigated. Finally, time trends of the number of cases, deaths, and CFR were investigated using ordinary least squares regression models. RESULTS: The total number of confirmed cases of COVID-19 was 3,090,184. The European region had the highest number of COVID-19 patients (1,434,649 [46.43%]). Ukraine with 10,406 and the USA with 1,003,974 cases have reported the lowest and highest confirmed cases, respectively. In addition, the European region and the African region with 157.13 and 2.50 patients per 100,000 population had the highest and the lowest incidence rate, respectively. India (2.44) and Spain (455.69) had the lowest and the highest incidence rate per 100,000 population, respectively. In the world, 217,759 deaths have happened, of which 135,961 (62.44%) were reported in the European region. Furthermore, the USA had the highest number of deaths (52,428) due to COVID-19. CFR was 7.05% in the world, which ranged from 3.74% in the African region and 9.48% in the European region. The number of patients and deaths due to COVID-19 had increasing trends in all countries, and the trend of CFR just for Iran and Ukraine was negative. CONCLUSION: The countries had different trends in the morbidity and mortality of COVID-19. However, regarding the increasing trend of the disease in the world, it will be more important to rely on public prevention strategies. It is necessary to apply and continue public health policies at national and global levels till the control of the disease. © 2020 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
2. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
3. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
4. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
5. Sars-Cov-2 and Covid-19, Evidence From a Literature Review: Review Article, Tehran University Medical Journal (2021)
6. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
7. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
8. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (18)
Seyed Ahmad Seyed Alinaghi (4)
Other Related Docs
9. Estimate of the Basic Reproduction Number for Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Public Health (2020)
10. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (Covid-19), Journal of Cardiovascular Pharmacology (2020)
11. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
12. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
13. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
14. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
15. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
16. Clinical Characteristics and Outcomes of 905 Covid-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran, Archives of Iranian Medicine (2020)
17. Epidemiology, Risk Factors, Species Distribution, and Antifungal Susceptibility of Candidemia Among Hospitalized Patients With Covid-19, Current Medical Mycology (2021)
18. Determine the Most Common Clinical Symptoms in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2020)
19. Immunomodulatory Effects of Nanocurcumin on Th17 Cell Responses in Mild and Severe Covid-19 Patients, Journal of Cellular Physiology (2021)
20. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)
21. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
22. Factors Associated With Mortality in Covid-19 Patients: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)
23. Modern Diagnostics Processes Among New Strains of Coronaviruses: A Review, Journal of Datta Meghe Institute of Medical Sciences University (2022)
24. Clinical Implications and Indicators of Mortality Among Patients Hospitalized With Concurrent Covid-19 and Myocardial Infarction, Turk Kardiyoloji Dernegi Arsivi (2021)
25. A Tempo-Geographic Analysis of Covid-19 and Vaccination in Emro Region: Joinpoint Regression in an Ecologic Study, Journal of Health Sciences and Surveillance System (2023)
26. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
27. The Return Visit, Outcome and Predicting Factors of Return Visit Among Suspected Covid-19 Outpatients, Internal and Emergency Medicine (2022)
28. A Comprehensive Review on Covid-19 Infection and Comorbidities of Various Organs, Acta Medica Iranica (2021)
29. Sars-Cov-2–A Tough Opponent for the Immune System, Archives of Medical Research (2020)
30. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
31. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
32. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
33. The Emergence of Novel Coronavirus Disease, Global Treatment Update and Its Containment Strategies in Overpopulated Countries: A Review, Coronaviruses (2021)
34. Ophthalmic Workplace Modifications for the Post-Covid Era, Journal of Ophthalmic and Vision Research (2020)
35. A Patient With Covid-19 Pneumonia Presenting With Plural Effusion: A Case Report, Infectious Disorders - Drug Targets (2021)
36. Investigation of Sars-Cov-2 Ability to Pass Through the Placenta, Shiraz E Medical Journal (2021)
37. Non-Steroidal Anti-Inflammatory Drugs in Management of Covid-19; a Systematic Review on Current Evidence, International Journal of Clinical Practice (2020)
38. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
39. The Prevalence and Factors Related to Healthcare Avoidance Among Women in Reproductive Age During Covid-19 Pandemic: A Cross-Sectional Study, Payesh (2024)
40. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
41. Epidemiological and Clinical Characteristics of Covid-19 Patients Studied by Jiroft University of Medical Sciences: Southeast of Iran, Journal of Advances in Medical and Biomedical Research (2021)
42. Clinical Manifestations of Gastrointestinal Symptoms in Covid-19 Patients: An Integrative Review, Gastroenterology Nursing (2021)
43. The Effect of Hiv/Aids Infection on the Clinical Outcomes of Covid-19: A Meta-Analysis, Journal of Pharmacy and Pharmaceutical Sciences (2022)
44. Sars-Cov-2 and Covid-19, Basic and Clinical Aspects of the Human Pandemic: A Review, Iranian Journal of Public Health (2021)
45. Development of a Multiepitope Vaccine Against Sars-Cov-2: Immunoinformatics Study, JMIR Bioinformatics and Biotechnology (2022)
46. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
47. Transmission Modes of Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2021)
48. Proinflammatory and Immunomodulatory Cytokine Mrna Changes by Real-Time Rt-Pcr in Patients With Covid-19 Hospitalization in the Icu and People Recovering From the Disease, Minerva Pneumologica (2020)
49. Pharmacotherapy for Prevention and Management of Thrombosis in Covid-19, Seminars in Thrombosis and Hemostasis (2020)
50. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)